Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateApimeds Pharmaceuticals US, Inc.
XASE•Health Care•Pharmaceutical Preparations
Flagged at $3.37 at 07:14 AM on Oct 05, then ran to $5.83 +73% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is APUS down today? It is at $2.69 (-7.08%), and our scanner flagged it 167 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment APUS spikes, and full due diligence on APUS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $APUS 167 times in the last 30 days. Create a free account to track $APUS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
APUS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on APUS today. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystInnovations Signs Agreement with US-Based BlockAssure to Build and Operate AssureChain, an End-to-End Insurance and Reinsurance NetworkReported agreement also provides for an allocation to MindWave equal to 20% of the total supply of AssureCoin, a digital token BlockAssure plansReported terms maintain MindWave's 20% share if additional AssureCoin is issued during the term or for two years afterward., from the latest SEC filing. Read it →Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
APUS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on APUS today. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
APUS last traded at $2.69, down 7.08% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Apimeds Pharmaceuticals US, Inc. (APUS) is next expected to report earnings on Wednesday, November 11, 2026, about 15 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The APUS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged APUS 167 times in the last 30 days.
APUS (Apimeds Pharmaceuticals US, Inc.) trades on XASE, with a market cap of about $4M in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge APUS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$APUS discussion
Sign in to ask a question or join the discussion.